States increasingly struggling to cover the rising cost of popular GLP-1 drugs like Wegovy, Ozempic and Zepbound are ...
Some states that cover the cost of drugs like Wegovy, Ozempic and Zepbound are scrambling to lessen the budgetary squeeze ...
The buy now, pay later model has taken off. Experts say BNPL can be useful when used responsibly, but shoppers should be careful not to overspend.
The Centers for Medicare and Medicaid Services said late Friday that it would not cover medications such as Wegovy that are ...
President Donald Trump’s team is rejecting former President Biden's plan to cover weight loss drugs like Wegovy and Zepbound for older Americans through Medicare. The Centers for Medicare and Medicaid ...
The injectable drugs have exploded in popularity due to the potentially life-changing weight loss that some patients ...
Explore more
Administration officials reversed a decision made during the Biden presidency that would have given millions of people access ...
Trump administration rejects a Biden plan to expand Medicare coverage of weight-loss drugs such as Zepbound and Wegovy.
The Biden administration proposal would have significantly expanded access to obesity to millions of Americans but would have cost the government billions.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results